CD63 and Miyoshi myopathy: MM BM-mesenchymal stromal cell (MSC)-derived exosomes, defined as CD63+/CD81+, promote MM tumor growth via downregulation of a tumor suppressor miR-15a; in contrast, normal BM-MSC exosomes inhibit growth of MM cells [12].